The II Moscow International Forum for Innovative Development “Open Innovations”, which was held in Moscow from October 31 to November 1, 2013, confirmed its role of a global discussion platform in the field of technological innovations.
For two consecutive years now, “Open Innovations” has become the largest event in Russia and one of the biggest events in the world, demonstrating the major trends and key developments in innovative sectors of the economy. Open Innovations Expo 2013, which exposition has become a unique platform for the development and demonstration of advanced technologies, exchange of experience in successful implementing of innovative projects, as well as effective interaction between government, science and business was held within the framework of the Forum.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/63505-results-open-innovations-forum-moscow-2013
Now entering its seventh year, diane magazine, published by Rodale Custom Content & Marketing on behalf of Curves fitness clubs for women, has now touched the lives of more than six million women.
To view Multimedia News Release, go to http://www.multivu.com/players/English/45110-rodale-marketing/
With years of business and military experience, this book plots your flight path to achieving the next level of growth in life and business. Learning to think like a fighter pilot will change how you approach everyday challenges and help shatter the barriers between you and the big blue open sky. Find out more at http://chuckgumbert.com Business/Non-Fiction
Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market and manufacturer of the industry's three premier brands: Thermage®, Fraxel®, and Isolaz®, is pleased to announce that it has partnered with PGA TOUR golfer Scott McCarron to raise awareness about skin protection and the Fraxel re:store® laser treatment. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin, including the removal of actinic keratoses (AK’s ) — a precancerous skin condition caused by sun exposure. Fraxel re:store treatment provides superior results for AKs on the face or other areas of the body displaying the signs of photodamage.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/solta/45388/
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
Interim clinical results from Project IMPACT: Diabetes, announced today by the American Pharmacists Association (APhA) Foundation, show statistically significant decreases in A1C or blood sugar levels, LDL cholesterol, systolic blood pressure and Body Mass Index (BMI), which are all recognized standards of diabetes care. Participating patients in 25 communities who experienced improved outcomes encompass almost every socioeconomic class, insurance status and ethnicity.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62268-american-pharmacists-association-apha-foundation-project-impact-diabetes
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
The largest-ever morbi-mortality study of treatments for chronic heart failure has shown that adding the specific heart rate lowering agent Procoralan® (ivabradine) to standard therapy significantly reduces the risk of death and hospitalisation for heart failure.1 Results from this new study, SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial), were presented today at the European Society of Cardiology1 in Stockholm and published in The Lancet.2
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shift/44195/
Thirty–nine percent of 12th–grade students have the mathematics skills and 38 percent the reading skills needed for entry–level college courses, according to results on the National Assessment of Educational Progress (NAEP), released today by the National Center for Education Statistics.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7226751-naep-national-scores-less-than-half-twelfth-graders-prepared-for-college
The Preeclampsia Foundation, the nation’s only non-profit patient advocacy organization for preeclampsia and related hypertensive disorders of pregnancy, today announced the results of a recent nationwide Preeclampsia Awareness Survey of more than 1,500 expectant and new mothers. These findings are driving the Foundation’s strategies associated with National Preeclampsia Awareness Month.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7171451-preeclampsia-foundation-awareness-survey-education-pregnancy-disorders
ARC is the first all-in-one content engagement platform that lets you easily, quickly and widely distribute your multimedia content – especially video - across multiple digital channels to all of your key audiences. Unlike widgets or microsites or passive media players, ARC brings together everything you need to drive content marketing results:
A highly accessible and interactive format. Massive distribution via PR Newswire’s industry-leading multimedia content distribution network. Dynamic, “on-the-fly” update-ability. Along with extreme speed, efficiency and measurability. No other digital platform does more to make your content marketing programs successfully deliver measurable results.
For more information, go to http://www.multivu.com/players/English/48198-PRNewswire-ARC-Marketing/
